Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hallvard Holdaas

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
Nephrology (Carlton, Vic.)|February 9, 2016
Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experienceElisabet Størset, Anders Åsberg, Anders Hartmann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 25, 2007
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipientsPål Falck, Nils Tore Vethe, Anders Asberg, et al.
Transplantation|February 1, 2013
Endothelial dysfunction is associated with graft loss in renal transplant recipientsDag Olav Dahle, Karsten Midtvedt, Anders Hartmann, et al.
Journal of the American Society of Nephrology : JASN|May 14, 2011
Rosuvastatin in diabetic hemodialysis patientsHallvard Holdaas, Ingar Holme, Roland E Schmieder, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 2009
Impaired glucose homeostasis in renal transplant recipients receiving basiliximabWilly Aasebø, Karsten Midtvedt, Tone Gretland Valderhaug, et al.
Journal of Translational Medicine|July 29, 2009
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot studySara Bremer, Nils T Vethe, Helge Rootwelt, et al.
International Journal of Environmental Research and Public Health|February 15, 2022
Use of Statins in Kidney Transplant Recipients in NorwayMarit Rønning, Vidar Hjellvik, Solveig Sakshaug, et al.
BMC Nephrology|January 13, 2017
Should patients older than 65 years be offered a second kidney transplant?Kristian Heldal, Anders Hartmann, Kjersti Lønning, et al.
Annals of the Rheumatic Diseases|April 4, 2014
Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritisHanne A Aulie, Anne M Selvaag, Anne Günther, et al.
Transplantation Research|February 2, 2013
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipientsHåvard Loftheim, Karsten Midtvedt, Anders Hartmann, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Nephrology (Carlton, Vic.)|February 9, 2016
Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experienceElisabet Størset, Anders Åsberg, Anders Hartmann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 25, 2007
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipientsPål Falck, Nils Tore Vethe, Anders Asberg, et al.
Transplantation|February 1, 2013
Endothelial dysfunction is associated with graft loss in renal transplant recipientsDag Olav Dahle, Karsten Midtvedt, Anders Hartmann, et al.
Journal of the American Society of Nephrology : JASN|May 14, 2011
Rosuvastatin in diabetic hemodialysis patientsHallvard Holdaas, Ingar Holme, Roland E Schmieder, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 2009
Impaired glucose homeostasis in renal transplant recipients receiving basiliximabWilly Aasebø, Karsten Midtvedt, Tone Gretland Valderhaug, et al.
Journal of Translational Medicine|July 29, 2009
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot studySara Bremer, Nils T Vethe, Helge Rootwelt, et al.
International Journal of Environmental Research and Public Health|February 15, 2022
Use of Statins in Kidney Transplant Recipients in NorwayMarit Rønning, Vidar Hjellvik, Solveig Sakshaug, et al.
BMC Nephrology|January 13, 2017
Should patients older than 65 years be offered a second kidney transplant?Kristian Heldal, Anders Hartmann, Kjersti Lønning, et al.
Annals of the Rheumatic Diseases|April 4, 2014
Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritisHanne A Aulie, Anne M Selvaag, Anne Günther, et al.
Transplantation Research|February 2, 2013
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipientsHåvard Loftheim, Karsten Midtvedt, Anders Hartmann, et al.
Pageof 16